|
|
|
|
 |
Autumn 2026 |
 |
|
|
|
|
The necessity of adding Hantavirus infection to the differential diagnosis of Iran syndromic surveillance
|
Seyyed Amir Yasin Ahmadi1   , Babak Eshrati2 , Manoochehr Karami3 , Fahimeh Bagheri Amiri *4 |
1- Student Research Committee, School of Public Health, Iran University of Medical Sciences, Tehran, Iran & Health Systems Engineering Research Center, Milad Hospital, Tehran, Iran
2- Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran
3- Pandemic and Epidemic Preparedness and Response Research Network, Research Institute for Health Sciences and Environment, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran , fahimehbagheriamiri@gmail.com |
|
|
Abstract: (5 Views) |
Iran’s syndromic surveillance system is continuously monitoring emerging infectious diseases. Given the serological and molecular evidence of hantavirus circulation in rodent reservoirs and the human population of the country, strengthening diagnostic approaches in this system is important. In addition to presenting with manifestations such as renal and respiratory syndromes, hantavirus requires a distinct place in the differential diagnosis protocols of acute respiratory and influenza-like infections. Utilizing existing laboratory capacities, along with ongoing training for early identification of suspicious cases, can significantly strengthen the current surveillance system in managing possible outbreaks and responding to these potential threats
Article Type: Letter to the Editor
Keywords: Hantavirus, Public Health Surveillance, Pandemic
Acknowledgments: We hereby extend our gratitude to the Center for Communicable Disease Management of the Ministry of Health for their technical consultation in the preparation of this manuscript.
Data Availability: Not applicable.
Conflict of Interest: The authors declare no conflicts of interest.
Consent for Publication: Not applicable.
Ethics Approval and Consent to Participate: Not applicable.
Financial Disclosure: This article received no specific funding.
Author Contributions: All authors contributed to the study design, writing, and editing of the manuscript. All authors have reviewed and approved the final manuscript and accept full responsibility for its content. |
|
| |
|
|
Full-Text [PDF 538 kb]
(3 Downloads)
|
|
Type of Study: Others |
Subject:
General
|
|
|
|
|
|
|
| References |
1. Khan A, Khan M, Ullah S, Wei DQ. Hantavirus: the next pandemic we are waiting for?. Interdisciplinary Sciences: Computational Life Sciences. 2021 Mar;13(1):147-52. [ DOI:10.1007/s12539-020-00413-4] [ PMID] [ PMCID] 2. Romeo MA, Tofani S, Lapa D, Mija C, Maggi F, Scicluna MT, Nardini R. Orthohantaviruses: An Overview of the Current Status of Diagnostics and Surveillance. Viruses. 2025 Apr 26;17(5):622. [ DOI:10.3390/v17050622] [ PMID] [ PMCID] 3. Karbalaei M, Sahebi S, Keikha M. Evidence of hantavirus circulation among the Iranian population: An emerging neglected tropical disease. Annals of Medicine and Surgery. 2022 Nov 1;83. [ DOI:10.1016/j.amsu.2022.104809] [ PMID] [ PMCID] 4. Tortosa F, Perre F, Tognetti C, Lossetti L, Carrasco G, Guaresti G, Iglesias A, Espasandin Y, Izcovich A. Seroprevalence of hantavirus infection in non-epidemic settings over four decades: a systematic review and meta-analysis. BMC Public Health. 2024 Sep 19;24(1):2553. [ DOI:10.1186/s12889-024-20014-w] [ PMID] [ PMCID] 5. Vial PA, Ferrés M, Vial C, Klingström J, Ahlm C, López R, Le Corre N, Mertz GJ. Hantavirus in humans: a review of clinical aspects and management. The Lancet Infectious Diseases. 2023 Sep 1;23(9):e371-82. [ DOI:10.1016/S1473-3099(23)00128-7] [ PMID] 6. Ramos-Nino ME, Chiem N, Ramdass PV. Hantavirus Emergence in a Changing World: Virology, Pathogenesis, Surveillance, and One Health Preparedness. 7. Friebe K, Waldherr R, Krautter M. Viral haemorrhagic fever and a skin rash-what is the link?. NDT plus. 2008 Jun 1;1(3):178-81. [ DOI:10.1093/ndtplus/sfn021] [ PMID] [ PMCID] 8. Zaki SR, w Greer P, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. The American journal of pathology. 1995 Mar;146(3):552. 9. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science. 1993 Nov 5;262(5135):914-7. [ DOI:10.1126/science.8235615] [ PMID] 10. Salehi‐Vaziri M, Kaleji AS, Fazlalipour M, Jalali T, Mohammadi T, Khakifirouz S, Baniasadi V, Pouriayevali MH, Mahmoudi A, Tordo N, Mostafavi E. Hantavirus infection in Iranian patients suspected to viral hemorrhagic fever. Journal of Medical Virology. 2019 Oct;91(10):1737-42. [ DOI:10.1002/jmv.25522] [ PMID] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Clinical trials code: موضوعیت ندارد
|
|
Open Access Statement: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium or format, provided that the original work is properly cited.
|
|
|
|
